ID

34472

Descripción

Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01040624

Link

https://clinicaltrials.gov/show/NCT01040624

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 27/5/19 27/5/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT01040624

Eligibility Prostate Cancer NCT01040624

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
* adenocarcinoma of the prostate.
Descripción

ID.1

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous prostate cancer treatment such as chemotherapy and/or pelvic radiation.
Descripción

ID.2

Tipo de datos

boolean

active inflammatory bowel disease (diverticulitis, crohn's disease or ulcerative colitis) affecting the rectum. (non-active diverticulitis and crohn's disease not affecting the rectum are allowed.)
Descripción

ID.3

Tipo de datos

boolean

history of hip replacement.
Descripción

ID.4

Tipo de datos

boolean

prior intrapelvic surgery. this includes the following:
Descripción

ID.5

Tipo de datos

boolean

transrectal or rectal surgery other than polypectomy or hemorrhoid removal or banding
Descripción

ID.6

Tipo de datos

boolean

transabdominal pelvic surgery
Descripción

ID.7

Tipo de datos

boolean

bladder surgery
Descripción

ID.8

Tipo de datos

boolean

prior mi (myocardial infarction) or chf (congestive heart failure).
Descripción

ID.9

Tipo de datos

boolean

taking saw palmetto or methotrexate and unable or unwilling to discontinue its use during radiation.
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Prostate Cancer NCT01040624

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
* adenocarcinoma of the prostate.
boolean
Item Group
C0680251 (UMLS CUI)
ID.2
Item
previous prostate cancer treatment such as chemotherapy and/or pelvic radiation.
boolean
ID.3
Item
active inflammatory bowel disease (diverticulitis, crohn's disease or ulcerative colitis) affecting the rectum. (non-active diverticulitis and crohn's disease not affecting the rectum are allowed.)
boolean
ID.4
Item
history of hip replacement.
boolean
ID.5
Item
prior intrapelvic surgery. this includes the following:
boolean
ID.6
Item
transrectal or rectal surgery other than polypectomy or hemorrhoid removal or banding
boolean
ID.7
Item
transabdominal pelvic surgery
boolean
ID.8
Item
bladder surgery
boolean
ID.9
Item
prior mi (myocardial infarction) or chf (congestive heart failure).
boolean
ID.10
Item
taking saw palmetto or methotrexate and unable or unwilling to discontinue its use during radiation.
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial